Treatment of advanced gastrointestinal tumors with genetically modified autologous mesenchymal stromal cells (TREAT-ME1): study protocol of a phase I/II clinical trial

BACKGROUND: Adenocarcinoma originating from the digestive system is a major contributor to cancer-related deaths worldwide. Tumor recurrence, advanced local growth and metastasis are key factors that frequently prevent these tumors from curative surgical treatment. Preclinical research has demonstra...

Full description

Saved in:
Bibliographic Details
Published in:BMC Cancer
Main Authors: Niess, Hanno, von Einem, Jobst C, Thomas, Michael N, Michl, Marlies, Angele, Martin K, Huss, Ralf, Günther, Christine, Nelson, Peter J, Bruns, Christiane J, Heinemann, Volker
Format: Artigo
Language:Inglês
Published: BioMed Central 2015
Subjects:
Study Protocol
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4393860/
https://ncbi.nlm.nih.gov/pubmed/25879229
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-015-1241-x
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items